Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1219130-57-0

Post Buying Request

1219130-57-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1219130-57-0 Usage

General Description

The chemical "7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one" is a compound with a complex molecular structure. It contains a 1,3,2-dioxaborolan-2-yl group and a benzo[b][1,4]oxazin-3(4H)-one group. The presence of the dioxaborolan-2-yl group suggests that the compound is potentially useful for Suzuki-Miyaura cross-coupling reactions, a common method for forming carbon-carbon bonds in organic synthesis. The benzo[b][1,4]oxazin-3(4H)-one group indicates that the compound may have biological activity, as molecules with similar structures have been studied for their antimicrobial and anticancer properties. Further research is needed to fully understand the potential uses and properties of this chemical.

Check Digit Verification of cas no

The CAS Registry Mumber 1219130-57-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,1,3 and 0 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1219130-57:
(9*1)+(8*2)+(7*1)+(6*9)+(5*1)+(4*3)+(3*0)+(2*5)+(1*7)=120
120 % 10 = 0
So 1219130-57-0 is a valid CAS Registry Number.

1219130-57-0Relevant articles and documents

SYK INHIBITORS

-

Paragraph 3283; 3289-3291, (2016/10/07)

The present disclosure a Syk compound inhibitors, including state cancer and inflammation and various disease States thereof in the treatment of relates to the use of. In one aspect a particular embodiment, . given by formula I which is marked as a chemical structure of compound. In formula said, X 1, X 2, X 3, R 2, R 3, R 4, R 5, and Y has described herein is. The present disclosure of a formula I compounds or a pharmaceutically acceptable salt of pharmaceutical compositions including, mediated by Syk and to treat conditions a employing these compounds and compositions further provides a method. (by machine translation)

HETEROCYCLIC BIARYL DERIVATIVE AND PDE INHIBITOR COMPRISING SAME AS ACTIVE INGREDIENT

-

Page/Page column 31-32, (2011/08/04)

Novel heterocyclic biaryl derivatives were disclosed which are useful as pharmaceutical agents and which exhibit a phosphodiesterase-inhibitory action. The heterocyclic biaryl derivatives are represented by the following general formula (1): wherein the H

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1219130-57-0